Lindbrook Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$89.7K Buy
1,405
+124
+10% +$7.2K 0.01% 723
2024
Q4
$61.2K Sell
1,281
-135
-10% -$6.92K 0.01% 732
2024
Q3
$81.1K Sell
1,416
-287
-17% -$16.5K 0.01% 629
2024
Q2
$89.2K Buy
1,703
+161
+10% +$7.06K 0.01% 574
2024
Q1
$62.7K Sell
1,542
-380
-20% -$14.2K 0.01% 693
2023
Q4
$71K Sell
1,922
-41
-2% -$1.54K 0.01% 632
2023
Q3
$75K Buy
1,963
+98
+5% +$4.01K 0.01% 548
2023
Q2
$67.3K Buy
1,865
+308
+20% +$10.5K 0.01% 613
2023
Q1
$59.5K Sell
1,557
-349
-18% -$16.4K 0.01% 630
2022
Q4
$108K Sell
1,906
-331
-15% -$16.9K 0.01% 460
2022
Q3
$88K Buy
2,237
+46
+2% +$2.03K 0.01% 466
2022
Q2
$96K Buy
2,191
+13
+0.6% +$562 0.02% 445
2022
Q1
$87K Sell
2,178
-1,110
-34% -$39.5K 0.01% 505
2021
Q4
$132K Buy
3,288
+3,245
+7,547% +$121K 0.02% 418
2021
Q3
$2K Hold
43
﹤0.01% 1542
2021
Q2
$2K Hold
43
﹤0.01% 1591
2021
Q1
$2K Hold
43
﹤0.01% 1549
2020
Q4
$2K Hold
43
﹤0.01% 1454
2020
Q3
$1K Buy
+43
New +$1.2K ﹤0.01% 1563
2020
Q2
Sell
-56
Closed -$1K 1778
2020
Q1
$1K Buy
+56
New +$1.06K ﹤0.01% 1463
2019
Q1
Sell
-1,000
Closed -$14K 1438
2018
Q4
$14K Buy
+1,000
New +$16K 0.01% 732

Other funds holding HALO

Lindbrook Capital's HALO Position: Q1 2025 in Review

Lindbrook Capital increased its Halozyme (HALO) stake by 9.7% in Q1 2025, buying an estimated $7.2K and bringing the position to 1,405 shares worth $89.7K. The position accounts for 0.01% of the portfolio, ranked #723.

Lindbrook Capital first reported a position in HALO in Q4 2018 and has held it in 21 quarters since. The position peaked at $132K in Q4 2021. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Lindbrook Capital held 1,405 shares of Halozyme worth $89.7K as of Q1 2025.
  • Lindbrook Capital bought 124 Halozyme shares in Q1 2025, an estimated $7.2K.
  • Halozyme made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #723 holding.
  • Lindbrook Capital first reported a position in Halozyme in Q4 2018 and has held it in 21 quarters since.
  • Lindbrook Capital's Halozyme position peaked at $132K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.